BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4948561)

  • 21. Preliminary clinical study of Wy 3707 with ethinyl estradiol as an oral contraceptive.
    O'Roark HC; Lock FR; Smith Foushee JH; Burt RL
    Int J Fertil; 1966; 11(4):405-11. PubMed ID: 5970363
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical trial with a combination of 150 mcg of d-norgestrel and 30 mcg of ethinylestradiol. Its metabolic effects].
    Moggia AV; Koremblit E; Beauquis A
    Obstet Ginecol Lat Am; 1976; 34(11-12):384-97. PubMed ID: 801618
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral conception and uterine size-ultrasonic study.
    Pirroinen O; Rauramo L
    Am J Obstet Gynecol; 1975 Jun; 122(3):349-51. PubMed ID: 1130457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-norgestrel combined with ethinyl oestradiol as an oral contraceptive.
    McBride WG
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):177-85. PubMed ID: 4985938
    [No Abstract]   [Full Text] [Related]  

  • 25. Fertility control with Ovral. A clinical review.
    Laurie RE; Lewis ET
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:95-107. PubMed ID: 4256548
    [No Abstract]   [Full Text] [Related]  

  • 26. A low-dose combination oral contraceptive. Experience with 1,700 women treated for 22,489 cycles.
    Woutersz TB
    J Reprod Med; 1981 Dec; 26(12):615-20. PubMed ID: 7033528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcortin as an indicator of estrogenic potency in oral contraceptives.
    Carol W; Börner A; Klinger G; Greinke C
    Endokrinologie; 1980 Mar; 75(2):167-72. PubMed ID: 6156820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergency contraception alters progesterone-associated endometrial protein in serum and uterine luminal fluid.
    Young DC; Wiehle RD; Joshi SG; Poindexter AN
    Obstet Gynecol; 1994 Aug; 84(2):266-71. PubMed ID: 8041545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antiepileptic drugs and oral contraceptives. Preliminary note].
    Meduri M; Bramanti B; Di Perri R; Volpe A; Oliva A; Baviera G
    Boll Soc Ital Biol Sper; 1978 Dec; 54(23):2462-7. PubMed ID: 756744
    [No Abstract]   [Full Text] [Related]  

  • 30. Elevation of serum prolactin during application of oral contraceptives.
    Dericks-Tan JS; Taubert HD
    Contraception; 1976 Jul; 14(1):1-8. PubMed ID: 975808
    [No Abstract]   [Full Text] [Related]  

  • 31. Observations with Anteovin with special regard to its cycle-regulating action.
    Hetényi G
    Ther Hung; 1987; 35(3):164-8. PubMed ID: 3438880
    [No Abstract]   [Full Text] [Related]  

  • 32. [Changes in carbohydrate metabolism brought about by combined oral contraceptives].
    De Oliveira MH; De Oliveira CF
    Gynecologie; 1978; 29(4):403-7. PubMed ID: 720724
    [No Abstract]   [Full Text] [Related]  

  • 33. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical observations with Rigevidon.
    Bálint S
    Ther Hung; 1980; 28(2):75-8. PubMed ID: 7466718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood platelet biochemistry in women receiving steroid contraceptives.
    Briggs M
    Haematologia (Budap); 1973; 7(3):347-67. PubMed ID: 4790074
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of oral contraceptives on vitamin B6 nutriture of young women.
    Vir SC; Love AH
    Int J Vitam Nutr Res; 1980; 50(1):29-34. PubMed ID: 7390712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of menstrual disorders with a combination of norgestrel and ethynyl estradiol.
    Rao KP
    Curr Med Pract; 1971; 15(1):586-9. PubMed ID: 12306340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contribution to the study of synthetic progestinics. Analysis of a 17-hydroxyprogesterone derivative combined with ethinyl-estradiol].
    Peano M; Agnese M; Yammaki Y; Araujo Peano N; Groisman M; Canedo A; Correa A; Villano G; Cardoso A
    Minerva Ginecol; 1969 Dec; 21(24):1667-94. PubMed ID: 5374678
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of oral contraceptive on alpha I-anti trypsin activity.
    Kishore N; Rizvi V; Kishore N; Sharma BB
    J Obstet Gynaecol India; 1979 Apr; 29(2):258-60. PubMed ID: 314914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.